Sustainability is deep rooted in all our decision making
We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
News Updates
1 OCTOBER 2024
Pharmaniaga Berhad (Pharmaniaga) is pleased to announce the appointment of Dato’ Seri Abdul Razak Jaafar as its new Independent Non-Executive Chairman, effective today. He succeeds Izaddeen Daud, who has held the position since February 2023, and as part of this strategic leadership transition, Izaddeen has been redesignated as Non-Independent Non-Executive Director.
19 SEPTEMBER 2024
Malaysia is set to achieve a significant milestone in healthcare with the production of locally manufactured human insulin, biosimilar and vaccines, following the launch of the country’s first locally owned biopharmaceutical plant by Pharmaniaga Berhad, officiated by Dato’ Seri Mohamed Khaled Nordin, Minister of Defence, today.
21 AUGUST 2024
Pharmaniaga Berhad’s (Pharmaniaga) strategic plan and initiatives placed the Group on the right track of recovery as it delivered robust financial results for the first half ended 30 June 2024 (1H FY2024) with Profit After Tax (PAT) rising to RM30.0 million, up from RM5.1 million in the same period last year.
5 JUNE 2024
Pharmaniaga Berhad (Pharmaniaga) will continue to leverage on improving operational efficiency and stringent cost control measures that has proven to have helped the Group to be resilient and re-emerged stronger amidst its challenging financial situation.
27 MAY 2024
Pharmaniaga Berhad (Pharmaniaga) today announces a strong performance in its first quarter ended 31 March 2024 (Q1 FY2024) with Profit After Zakat and Taxation (PAT) surged almost tenfold to RM26.2 million, up from RM2.8 million in the same quarter last year, signalling a robust financial recovery.
10 MAY 2024
Pharmaniaga Berhad (Pharmaniaga) stands firm with its commitment to financial recovery amidst the opinion of its independent auditor PricewaterhouseCoopers (PWC) on the Group’s 2023 financial statement, dated 29 March 2024.
29 FEBRUARY 2024
Pharmaniaga Berhad (Pharmaniaga) today announces the appointment of Zulkifli Jafar as its Executive Director, marking a pivotal move to navigate the turnaround of the Group, after the successful submission of Regularisation Plan to Bursa Malaysia within the stipulated timeline.
23 FEBRUARY 2024
Pharmaniaga Berhad announced today its significant step towards financial revitalisation by submitting the Regularisation Plan to Bursa Malaysia. This move marks a critical milestone by the Group to recover and enhance its financial standing, aiming to exit its Practice Note 17 (PN17) status.
29 NOVEMBER 2023
Pharmaniaga Berhad’s (Pharmaniaga) announces its plan to raise up to RM655 million to
bolster its financial position and revitalise financial health, marking a crucial step toward
exiting its Practice Note 17 (PN17) status.